Key terms
About KALA
KALA BIO, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest KALA news
KALA Financials
Key terms
Ad Feedback
KALA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
KALA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range